Delivery Order SPE2DB24D1104-SPE2DB25FYEL0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,051.05 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 11, 2025, with an ultimate completion date of August 12, 2025. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $3,073.44 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a ceiling value of $1,735.26. This firm fixed-price delivery order, which must be completed by August 11, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement. The contract carries no set-aside designation, indicating it was competitively awarded....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,584.22 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 8, 2025, with performance to be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating open competition among qualified pharmaceutical distributors....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $1,772.87 with a completion date of July 31, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents pharmaceutical procurement under the company's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pens valued at $5,236.50 on July 29, 2025, with completion scheduled for July 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Trulicity 0.75 mg/0.5 mL pens on July 24, 2025. The contract, valued at $1,889.60 with a firm fixed price structure, represents a single delivery order under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). This award was competitively made with no set-aside designation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens valued at $1,552.42. This is a firm fixed-price, non-set-aside contract with performance completion scheduled for August 6, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a $3,415.89 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on July 25, 2025, with a completion date of July 28, 2025. This firm fixed-price contract, which was not set-aside, represents a small delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, the company's corporate headquarters...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYEL0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens valued at $1,123.98. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a non-competitive set-aside transaction. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Trulicity, a diabetes medication, falls within the therapeutic categories covered under this prime vendor agreement, which encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies for the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/11/25 |